These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 24830404)

  • 1. Pitfalls of intranasal naloxone.
    Zuckerman M; Weisberg SN; Boyer EW
    Prehosp Emerg Care; 2014; 18(4):550-4. PubMed ID: 24830404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naloxone Dosing After Opioid Overdose in the Era of Illicitly Manufactured Fentanyl.
    Carpenter J; Murray BP; Atti S; Moran TP; Yancey A; Morgan B
    J Med Toxicol; 2020 Jan; 16(1):41-48. PubMed ID: 31471760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-Based Guidelines for EMS Administration of Naloxone.
    Williams K; Lang ES; Panchal AR; Gasper JJ; Taillac P; Gouda J; Lyng JW; Goodloe JM; Hedges M
    Prehosp Emerg Care; 2019; 23(6):749-763. PubMed ID: 30924736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naloxone administration for suspected opioid overdose: An expanded scope of practice by a basic life support collegiate-based emergency medical services agency.
    Jeffery RM; Dickinson L; Ng ND; DeGeorge LM; Nable JV
    J Am Coll Health; 2017 Apr; 65(3):212-216. PubMed ID: 28059635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of naloxone nasal spray 4 mg in the community setting: a survey of use by community organizations.
    Avetian GK; Fiuty P; Mazzella S; Koppa D; Heye V; Hebbar P
    Curr Med Res Opin; 2018 Apr; 34(4):573-576. PubMed ID: 28535115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An increase in per-patient naloxone requirements in an opioid epidemic.
    Birmingham LE; Nielson JA
    Am J Emerg Med; 2017 Dec; 35(12):1958-1959. PubMed ID: 28633907
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence of mortality due to rebound toxicity after 'treat and release' practices in prehospital opioid overdose care: a systematic review.
    Greene JA; Deveau BJ; Dol JS; Butler MB
    Emerg Med J; 2019 Apr; 36(4):219-224. PubMed ID: 30580317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naloxone Administration for Opioid Overdose Reversal in the Prehospital Setting: Implications for Pharmacists.
    Weaver L; Palombi L; Bastianelli KMS
    J Pharm Pract; 2018 Feb; 31(1):91-98. PubMed ID: 28399697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fact vs. fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids.
    Dahan A; Franko TS; Carroll JW; Craig DS; Crow C; Galinkin JL; Garrity JC; Peterson J; Rausch DB
    Front Public Health; 2024; 12():1346109. PubMed ID: 38481848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal naloxone is a viable alternative to intravenous naloxone for prehospital narcotic overdose.
    Robertson TM; Hendey GW; Stroh G; Shalit M
    Prehosp Emerg Care; 2009; 13(4):512-5. PubMed ID: 19731165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic.
    Fairbairn N; Coffin PO; Walley AY
    Int J Drug Policy; 2017 Aug; 46():172-179. PubMed ID: 28687187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose.
    Kerr D; Kelly AM; Dietze P; Jolley D; Barger B
    Addiction; 2009 Dec; 104(12):2067-74. PubMed ID: 19922572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing methods of naloxone administration: A narrative review.
    Fellows SE; Coppola AJ; Gandhi MA
    J Opioid Manag; 2017; 13(4):253-260. PubMed ID: 28953317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, Efficacy, and Cost of 0.4-mg Versus 2-mg Intranasal Naloxone for Treatment of Prehospital Opioid Overdose.
    Thompson J; Salter J; Bui P; Herbert L; Mills D; Wagner D; Brent C
    Ann Pharmacother; 2022 Mar; 56(3):285-289. PubMed ID: 34229467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic and Advanced EMS Providers Are Equally Effective in Naloxone Administration for Opioid Overdose in Northern New England.
    Gulec N; Lahey J; Suozzi JC; Sholl M; MacLean CD; Wolfson DL
    Prehosp Emerg Care; 2018; 22(2):163-169. PubMed ID: 29023172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose.
    Glaser A; Arakaki D; Chan GM; Hoffman RS
    Med J Aust; 2005 Apr; 182(8):427; author reply 427, 429. PubMed ID: 15850442
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical Pharmacokinetics and Pharmacodynamics of Naloxone.
    Saari TI; Strang J; Dale O
    Clin Pharmacokinet; 2024 Apr; 63(4):397-422. PubMed ID: 38485851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of Naloxone Redosing in the Age of the New Opioid Epidemic.
    Klebacher R; Harris MI; Ariyaprakai N; Tagore A; Robbins V; Dudley LS; Bauter R; Koneru S; Hill RD; Wasserman E; Shanes A; Merlin MA
    Prehosp Emerg Care; 2017; 21(6):682-687. PubMed ID: 28686547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Complications of Opioid Overdose Treated With Naloxone.
    Farkas A; Lynch MJ; Westover R; Giles J; Siripong N; Nalatwad A; Pizon AF; Martin-Gill C
    Ann Emerg Med; 2020 Jan; 75(1):39-48. PubMed ID: 31182316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal naloxone for life threatening opioid toxicity.
    Kelly AM; Koutsogiannis Z
    Emerg Med J; 2002 Jul; 19(4):375. PubMed ID: 12101174
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.